Investing
1191 Articles
A new earnings reporting season kicks off this week, with the big banks and a few other companies leading the…
President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of…
These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that…
The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of…
The race for finding the COVID-19 vaccine is in full swing, and it has just seen one team move ahead…
America and the rest of the world is getting ready for a vaccine that will help protect public health against…
Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but…
After Momenta Pharmaceuticals announced that it would be acquired by pharmaceutical giant Johnson & Johnson, the biotechnology company's shares soared…
Johnson & Johnson has announced that it will launch its human study for its lead vaccine candidate in the United…
Credit Suisse has assembled its favorite health care recovery stocks for a recovering base of elective surgeries and for the…
If you are a bond and income investor now, times are grim. One analyst says that the best income portfolio…
Many investors feel like the key stocks in the market have simply gotten away from them, but those fears are…
Stocks were looking for direction on Monday ahead of this week’s earnings deluge. With an election coming up and with…
Johnson & Johnson released better than expected quarterly results and guidance before the markets opened on Thursday.
Here, 24/7 Wall St. offers a preview of what to expect from Delta Air Lines, Netflix, PepsiCo and some of…
Our top personal finance-related articles today. Your wallet will thank you later.